| 1 | [SID17509735] | Active | Potency | 10 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 2 | [SID17509735] | Active | | | Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA) [AID651718, Type: screening] | MSRA protein [Bos taurus] [gi:73586699] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Active | | BioAssay | Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA) | | AID | 651718 | | BioAssay type | screening | | Target | MSRA protein [Bos taurus] [gi:73586699] | | PubMed | | | Data Table |  |
|
| 3 | [SID17509735] | Active | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID17509735] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 5 | [SID17509735] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 6 | [SID17509735] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 7 | [SID17509735] | Active | | | Antagonist of Human D 1 Dopamine Receptor: qHTS [AID504652, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Active | | BioAssay | Antagonist of Human D 1 Dopamine Receptor: qHTS | | AID | 504652 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 8 | [SID17509735] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 9 | [SID17509735] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 10 | [SID17509735] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 11 | [SID17509735] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 12 | [SID17509735] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 13 | [SID17509735] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 14 | [SID17509735] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 15 | [SID17509735] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 16 | [SID17509735] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 17 | [SID17509735] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 18 | [SID17509735] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 19 | [SID17509735] | Inactive | | | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase [AID2805, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase | | AID | 2805 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 20 | [SID17509735] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase [AID2806, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase | | AID | 2806 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 21 | [SID17509735] | Inactive | Potency | | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504466, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504466 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 22 | [SID17509735] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. [AID2023, Type: screening] | LAP4 [Saccharomyces cerevisiae] [gi:486173] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. | | AID | 2023 | | BioAssay type | screening | | Target | LAP4 [Saccharomyces cerevisiae] [gi:486173] | | PubMed | | | Data Table |  |
|
| 23 | [SID17509735] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN. [AID2025, Type: screening] | RPL19A [Saccharomyces cerevisiae] [gi:536029] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN. | | AID | 2025 | | BioAssay type | screening | | Target | RPL19A [Saccharomyces cerevisiae] [gi:536029] | | PubMed | | | Data Table |  |
|
| 24 | [SID17509735] | Inactive | Potency | | Activators of T cell receptors: qHTS campaign [AID504894, Type: confirmatory] | T cell receptor [Homo sapiens] [gi:553160] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Activators of T cell receptors: qHTS campaign | | AID | 504894 | | BioAssay type | confirmatory | | Target | T cell receptor [Homo sapiens] [gi:553160] | | PubMed | | | Data Table |  |
|
| 25 | [SID17509735] | Inactive | | | Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound [AID1979, Type: screening] | heat shock protein 90 [Candida albicans] [gi:994798] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound | | AID | 1979 | | BioAssay type | screening | | Target | heat shock protein 90 [Candida albicans] [gi:994798] | | PubMed | | | Data Table |  |
|
| 26 | [SID17509735] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. [AID2016, Type: screening] | MEP2 [Saccharomyces cerevisiae] [gi:1302091] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. | | AID | 2016 | | BioAssay type | screening | | Target | MEP2 [Saccharomyces cerevisiae] [gi:1302091] | | PubMed | | | Data Table |  |
|
| 27 | [SID17509735] | Inactive | | | Identification and characterization of compounds for addressing human bone marrow failure [AID817, Type: other] | unnamed protein product [Saccharomyces cerevisiae] [gi:1360328] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Identification and characterization of compounds for addressing human bone marrow failure | | AID | 817 | | BioAssay type | other | | Target | unnamed protein product [Saccharomyces cerevisiae] [gi:1360328] | | PubMed | | | Data Table |  |
|
| 28 | [SID17509735] | Inactive | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2177, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2177 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 29 | [SID17509735] | Inactive | Potency | | qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding [AID2675, Type: confirmatory] | muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding | | AID | 2675 | | BioAssay type | confirmatory | | Target | muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591] | | PubMed | | | Data Table |  |
|
| 30 | [SID17509735] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 31 | [SID17509735] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 32 | [SID17509735] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 33 | [SID17509735] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 34 | [SID17509735] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 35 | [SID17509735] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 36 | [SID17509735] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 37 | [SID17509735] | Inactive | | | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1 [AID1009, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1 | | AID | 1009 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 38 | [SID17509735] | Inactive | | | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1 [AID1009, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1 | | AID | 1009 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 39 | [SID17509735] | Inactive | | | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1 [AID1009, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1 | | AID | 1009 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 40 | [SID17509735] | Inactive | | | uHTS of Mcl-1/Bid interaction inhibitors [AID1021, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | uHTS of Mcl-1/Bid interaction inhibitors | | AID | 1021 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 41 | [SID17509735] | Inactive | | | uHTS of Mcl-1/Bid interaction inhibitors [AID1021, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | uHTS of Mcl-1/Bid interaction inhibitors | | AID | 1021 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 42 | [SID17509735] | Inactive | | | uHTS of Mcl-1/Bid interaction inhibitors [AID1021, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | uHTS of Mcl-1/Bid interaction inhibitors | | AID | 1021 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 43 | [SID17509735] | Inactive | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 44 | [SID17509735] | Inactive | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 45 | [SID17509735] | Inactive | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 46 | [SID17509735] | Inactive | | | E3 Ligase HTS_1536 [AID1230, Type: screening] | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | E3 Ligase HTS_1536 | | AID | 1230 | | BioAssay type | screening | | Target | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] | | PubMed | | | Data Table |  |
|
| 47 | [SID17509735] | Inactive | | | E3 Ligase HTS_1536 [AID1230, Type: screening] | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | E3 Ligase HTS_1536 | | AID | 1230 | | BioAssay type | screening | | Target | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] | | PubMed | | | Data Table |  |
|
| 48 | [SID17509735] | Inactive | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 49 | [SID17509735] | Inactive | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 50 | [SID17509735] | Inactive | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17509735 | | CID | 20846828 | | Outcome | Inactive | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|